Top 5 players in US Biosimilar Market STORY OUTLINE Pfizer: Excelling in the line of Biosimilar drugs with an experience of more than 10 years with presence in over 180 countries. Amgen: Making pharmaceutical products with an experience of over 40 years and presence in over 100 countries. Viartis: Presence in over 165 countries, and making Biosimilar drugs in over 75 markets,… Read More »
The US Biosimilar market is expected to reach ~USD 96 Bn Industry by 2028 The United States Biosimilar market which currently has a market size of ~USD 9.48 Bn. is expected to grow at a CAGR of ~40% in the next five years and become a ~USD 96 Bn. industry as per the findings of Ken Research. STORY OUTLINE Biosimilar drugs tend to be cost effective and this reason… Read More »
